ENDONOVO THERAPEUTICS, INC. Proceeds from Sale of Securities, Operating Activities
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Proceeds from Sale of Securities, Operating Activities of $2.10 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities · last filed 2016-11-14
- ENDONOVO THERAPEUTICS, INC. proceeds from sale of securities, operating activities for the quarter ending 2016-09-30 was $800.00K.
- ENDONOVO THERAPEUTICS, INC. proceeds from sale of securities, operating activities for the quarter ending 2016-06-30 was $650.00K.
- ENDONOVO THERAPEUTICS, INC. proceeds from sale of securities, operating activities for the quarter ending 2016-03-31 was $650.00K.
| Period end | Proceeds from Sale of Securities, Operating Activities 3 month | Proceeds from Sale of Securities, Operating Activities 6 month | Proceeds from Sale of Securities, Operating Activities 9 month |
|---|---|---|---|
| 2016-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.45M derived: sum of 2 quarters · filed 2016-11-14 | $2.10M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $650.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $1.30M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $650.00K 10-Q · filed 2016-05-27 |